Valuation PCL, Inc.

Stocks

End-of-day quote Korea S.E. 2025-03-21			5-day change	1st Jan Change
6,040.00 ^KRW	-1.63%		-.--%	-

24-12-29	Yeom Ju-hwan agreed to acquire 36.90% stake in mCureX Therapeutics, Inc. from PCL, Inc. for KRW 13.0 billion.	CI
24-08-29	PCL, Inc. announced that it has received KRW 4.004999835 billion in funding	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024
Market Cap ¹	368,384	365,077	175,405	184,730	32,781
Change	-	-0.9%	-51.95%	5.32%	-82.25%
Enterprise Value (EV) ¹	367,580	356,895	174,119	191,934	39,811
Change	-	-2.91%	-51.21%	10.23%	-79.26%
P/E	18.6x	-11.4x	-39.2x	-7.17x	-0.59x
PBR	10x	25.3x	5.66x	5.2x	4.61x
PEG	-	0x	0.4x	-0x	-0x
Capitalization / Revenue	6.86x	7.91x	4.71x	21.9x	26.3x
EV / Revenue	6.85x	7.73x	4.68x	22.8x	31.9x
EV / EBITDA	13.6x	-15x	-30.5x	-14.2x	-1.61x
EV / EBIT	14.3x	-13.9x	-21x	-11.7x	-1.46x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	13,116	-20,853	-2,543	-10,005	-18,642
Distribution rate	-	-	-	-	-
Net sales ¹	53,683	46,148	37,217	8,430	1,246
EBITDA ¹	27,027	-23,734	-5,717	-13,505	-24,676
EBIT ¹	25,676	-25,766	-8,303	-16,370	-27,239
Net income ¹	19,509	-31,669	-4,018	-20,318	-52,339
Net Debt ¹	-803.5	-8,182	-1,285	7,204	7,030
Reference price ²	243,666.67	237,000.00	99,666.67	71,700.00	11,080.00
Nbr of stocks (in thousands)	1,512	1,540	1,760	2,576	2,959
Announcement Date	3/30/22	3/30/22	3/23/23	3/20/24	3/23/25

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
PCL, INC.	-	-	-	-	12.32M
WUXI APPTEC CO., LTD.	17.43x	6.68x	12.81x	1.71%	66.7B
ARGENX SE	30.07x	8.27x	26.77x	0.07%	56.88B
LONZA GROUP AG	38.45x	6.84x	20.45x	0.85%	56.53B
BEONE MEDICINES AG	46.55x	6.14x	30.16x	-.--%	46.49B
IQVIA HOLDINGS INC.	35.48x	3.35x	14.48x	-.--%	44.8B
REVOLUTION MEDICINES, INC.	-22.71x	62.58x	-21.48x	-.--%	41.59B
CELLTRION, INC.	35.87x	8.84x	23.03x	0.37%	35.35B
GENMAB A/S	41.46x	8.08x	26.8x	-.--%	33.29B
INSMED INCORPORATED	-69.81x	13.21x	-71.01x	-.--%	25.1B
Average	16.98x	13.78x	6.89x	0.33%	40.67B
Weighted average by Cap.	21.52x	12.92x	11.34x	0.44%